Phibro Animal Health (NASDAQ:PAHC) Hits New 12-Month High – Still a Buy?

Phibro Animal Health Corporation (NASDAQ:PAHC) shares hit a new 52-week high during trading on Wednesday . The company traded as high as $56.90 and last traded at $56.3550, with a volume of 26105 shares traded. The stock had previously closed at $55.48.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on PAHC shares. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of Phibro Animal Health in a research note on Monday, December 29th. Morgan Stanley set a $49.00 price objective on Phibro Animal Health in a research note on Friday, February 6th. Finally, Zacks Research raised shares of Phibro Animal Health from a “hold” rating to a “strong-buy” rating in a report on Wednesday, March 11th. One analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Phibro Animal Health currently has an average rating of “Moderate Buy” and an average price target of $37.50.

Phibro Animal Health Price Performance

The company has a current ratio of 3.05, a quick ratio of 1.22 and a debt-to-equity ratio of 2.14. The stock has a 50 day simple moving average of $48.81 and a 200-day simple moving average of $43.22. The firm has a market cap of $2.26 billion, a PE ratio of 24.81, a price-to-earnings-growth ratio of 0.88 and a beta of 0.74.

Phibro Animal Health (NASDAQ:PAHC) last released its quarterly earnings data on Wednesday, February 4th. The company reported $0.87 earnings per share for the quarter, topping analysts’ consensus estimates of $0.69 by $0.18. Phibro Animal Health had a return on equity of 38.28% and a net margin of 6.29%.The firm had revenue of $373.91 million during the quarter, compared to analyst estimates of $355.64 million. Phibro Animal Health has set its FY 2026 guidance at 2.930-3.100 EPS. Equities analysts anticipate that Phibro Animal Health Corporation will post 1.95 earnings per share for the current fiscal year.

Phibro Animal Health Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, March 25th. Shareholders of record on Wednesday, March 4th were paid a $0.12 dividend. This represents a $0.48 annualized dividend and a yield of 0.9%. The ex-dividend date was Wednesday, March 4th. Phibro Animal Health’s dividend payout ratio is presently 21.33%.

Insider Transactions at Phibro Animal Health

In other news, CEO Jack Bendheim sold 7,040 shares of Phibro Animal Health stock in a transaction that occurred on Thursday, March 19th. The shares were sold at an average price of $52.52, for a total transaction of $369,740.80. Following the sale, the chief executive officer owned 73,320 shares in the company, valued at $3,850,766.40. This trade represents a 8.76% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Over the last ninety days, insiders have sold 316,800 shares of company stock worth $15,278,569. Company insiders own 50.13% of the company’s stock.

Hedge Funds Weigh In On Phibro Animal Health

Hedge funds and other institutional investors have recently modified their holdings of the stock. Penserra Capital Management LLC bought a new position in shares of Phibro Animal Health during the 3rd quarter valued at about $519,000. Capricorn Fund Managers Ltd purchased a new position in shares of Phibro Animal Health during the third quarter valued at about $10,233,000. Allspring Global Investments Holdings LLC bought a new stake in shares of Phibro Animal Health in the third quarter worth about $8,931,000. Citigroup Inc. increased its holdings in shares of Phibro Animal Health by 112.3% in the third quarter. Citigroup Inc. now owns 54,941 shares of the company’s stock worth $2,223,000 after purchasing an additional 29,066 shares during the last quarter. Finally, Squarepoint Ops LLC purchased a new stake in shares of Phibro Animal Health in the second quarter worth about $813,000. Institutional investors own 99.34% of the company’s stock.

About Phibro Animal Health

Phibro Animal Health Corporation (NASDAQ: PAHC) is a diversified global animal health and mineral nutrition company headquartered in Teaneck, New Jersey. The company develops, manufactures and markets a broad range of pharmaceutical, mineral nutrition and performance products designed to support the health and productivity of livestock, companion animals and aquaculture species. Phibro’s portfolio includes vaccines, anti-infective therapies, coccidiostats, disinfectants, premix minerals and specialty feed additives aimed at enhancing growth, immunity and overall animal well-being.

The company operates through three principal business segments: Animal Health, Mineral Nutrition and Performance Products.